Erythromycin Ethylsuccinate Granule, For Suspension
Product Images NDC 62559-440

3 FDA label images from Ani Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin Ethylsuccinate (NDC 62559-440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Image 01

Image 01
Label for Erythromycin Ethylsuccinate oral suspension USP granules, with an erythromycin activity strength of 200 mg per 5 mL when reconstituted. The product is a 200 mL bottle for oral use, manufactured by ANI Pharmaceuticals, Inc. The label includes preparation instructions and dosage notes.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of erythromycin ethylsuccinate showing its molecular arrangement including rings, hydroxyl groups, and ester functionalities typical of this macrolide antibiotic derivative.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.